Ετικέτες

Σάββατο 11 Αυγούστου 2018

A personal series of 100 children operated for Cushing’s disease (CD): optimizing minimally invasive diagnosis and transnasal surgery to achieve nearly 100% remission including reoperations

Journal Name: Journal of Pediatric Endocrinology and Metabolism
Issue: Ahead of print


https://ift.tt/2B4oVhI

Tetrathiomolybdate, a copper chelator inhibited imiquimod-induced skin inflammation in mice

Publication date: Available online 11 August 2018

Source: Journal of Dermatological Science

Author(s): Peng-Yang Hsu, Hsu-Heng Yen, Tao-Hsiang Yang, Che-Chun Su

Abstract
Background

Copper is an essential metal for maintenance of many biological functions; however, excessive amount can induce inflammation and oxidative stress. Tetrathiomolybdate (TM) is a copper chelator for treatment of Wilson's disease, and decreased the severity of autoimmune arthritis in mice.

Objective

In this report, we evaluated the effects of TM in a mouse model for psoriasis.

Methods

Imiquimod-induced psoriasis murine model was used. We applied immunohistochemistry staining and ELISA to determine levels of cytokines in the inflamed skin, splenocytes, and draining lymph nodes. In addition, we used keratinocytes and splenocytes to test the inhibitory effects of TM on cytokine production and activation of transcription factors.

Results

Our results showed that TM significantly reduced cumulative scores, epidermis thickness, and ki-67 expression in the inflamed skin. In addition, TM decreased skin cytokine levels and systemic inflammation. Moreover, TM suppressed activation in keratinocytes and splenocytes with reduction in phosphorylation of Erk1/2 and STAT3.

Conclusion

These findings are strong evidence that TM can inhibit psoriasis in the model.



https://ift.tt/2MjT9S7

Uptake and accumulation of polycyclic aromatic hydrocarbons in the mangroves Avicennia marina and Rhizophora mucronata

Abstract

This study investigated the uptake and accumulation of polycyclic aromatic hydrocarbons (PAHs) in two mangrove species, Avicennia marina and Rhizophora mucronata. We tested the hypothesis that A. marina would absorb and accumulate more PAHs than R. mucronata. One-year old seedlings of both species were subjected to Bunker Fuel Oil 180 for 3 weeks, and the concentration of PAHs was analyzed by gas chromatography-mass spectrometry (GC/MS). The concentration of PAHs was significantly higher in A. marina than in R. mucronata. The major portion of the PAH pool was in roots (96% in A. marina, 98% in R. mucronata) compared to leaves. The dominant PAHs in roots of both species possessed two to three rings and included phenanthrene, anthracene, fluorene, and acenaphthene. In shoots, PAHs in A. marina included phenanthrene, chrysene, anthracene, acenaphthene, benzo[k+b]fluoranthene, pyrene, benzo[a] anthracene, and benzo[a] pyrene, while those in R. mucronata included phenanthrene, naphthalene, fluoranthene, fluorene, and acenaphthene. Phenanthrene was the dominant PAH in roots and shoots of both species. The greater susceptibility of A. marina appears to be due to its greater root length and specific root length, which permit more exposure to oil than R. mucronata. Other contributory factors include root anatomical characteristics such as larger air spaces, lower suberization of root epidermal cells, lower concentrations of polyphenols, tannins, lignin, and a less efficient antioxidative system. This study provides novel information on differences in the uptake and accumulation of PAHs in two contrasting mangrove species.



https://ift.tt/2vZi6Il

Altered topology of the functional speech production network in non-fluent/agrammatic variant of PPA

Publication date: Available online 11 August 2018

Source: Cortex

Author(s): M.L. Mandelli, E. Vilaplana, A.E. Welch, C. Watson, G. Battistella, J.A. Brown, K.L. Possin, H.I. Hubbard, Z.A. Miller, M.L. Henry, G.A. Marx, M.A. Santos-Santos, L.P. Bajorek, J. Fortea, A. Boxer, G. Rabinovici, S. Lee, J. Deleon, H.J. Rosen, B.L. Miller

Abstract

Non-fluent/agrammatic primary progressive aphasia (nfvPPA) is caused by neurodegeneration within the left fronto-insular speech and language production network (SPN). Graph theory is a branch of vmathematics that studies the network architecture (topology) by quantifying features based on its elements (nodes and connections). This approach has been recently applied to neuroimaging data to explore the complex architecture of the brain connectome, though few studies exploited this technique in PPA. Here, we used graph theory on functional MRI resting state data of a group of 20 nfvPPA patients and 20 matched controls to investigate topological changes in response to focal neurodegeneration. We hypothesized that changes in the network architecture would be specific to the affected SPN in nfvPPA, while preserved in the spared default mode network (DMN). Topological configuration was quantified by hubs' location and global network's metrics. Our findings showed a less efficiently wired and less optimally clustered SPN, while no changes were detected in the DMN. The SPN in the nfvPPA group showed a loss of hubs in the left fronto-parietal-temporal area and new critical nodes in the anterior left inferior-frontal and right frontal regions. Behaviorally, speech production score and rule violation errors correlated with the strength of functional connectivity of the left (lost) and right (new) regions respectively. This study shows that focal neurodegeneration within the SPN in nfvPPA is associated with network-specific topological alterations, with loss and gain of crucial hubs and decreased global efficiency that were better accounted for by functional rather than structural changes. These findings support the hypothesis of selective network vulnerability in nfvPPA and may offer biomarkers for future behavioral intervention.



https://ift.tt/2vXgxuF

Monogenic polyautoimmunity in primary immunodeficiency diseases

Publication date: Available online 11 August 2018

Source: Autoimmunity Reviews

Author(s): Gholamreza Azizi, Reza Yazdani, Wiliam Rae, Hassan Abolhassani, Manuel Rojas, Asghar Aghamohammadi, Juan-Manuel Anaya

Abstract

Primary immunodeficiency diseases (PIDs) consist of a large group of genetic disorders that affect distinct components of the immune system. PID patients are susceptible to infection and non-infectious complications, particularly autoimmunity. A specific group of monogenic PIDs are due to mutations in genes that are critical for the regulation of immunological tolerance and immune responses. This group of monogenic PIDs is at high risk of developing polyautoimmunity (i.e., the presence of more than one autoimmune disease in a single patient) because of their impaired immunity. In this review, we discuss the mechanisms of autoimmunity in PIDs and the characteristics of polyautoimmunity in the following PIDs: IPEX; monogenic IPEX-like syndrome; LRBA deficiency; CTLA4 deficiency; APECED; ALPS; and PKCδ deficiency.



https://ift.tt/2B2UIj5

The link between immunity, autoimmunity and endometriosis: a literature update

Publication date: Available online 11 August 2018

Source: Autoimmunity Reviews

Author(s): Tao Zhang, Caterina De Carolis, Man Gene Chi-Wai, Chi-Chiu Wang

Abstract

Endometriosis (EMS), an estrogen-dependent inflammatory disorder affects approximately 5–10% of the general female population of reproductive age and 20–90% of women with pelvic pain and infertility. Many immunological factors are known to contribute significantly to the pathogenesis and pathophysiology of EMS, and both chronic local inflammation and autoantibodies in EMS shares many similarities with autoimmune diseases (AD). However, the autoimmune etiology in EMS remains controversial, and its evidence on autoimmune basis may be limited. Here we aim to review the current understanding between autoimmunity and EMS to provide important knowledge to develop future potential immunomodulatory therapy for the treatment of EMS.



https://ift.tt/2P2n283

Negative-pressure wound therapy for management of chronic neuropathic noninfected diabetic foot ulcerations – short-term efficacy and long-term outcomes

Abstract

Purpose

Negative pressure wound therapy (NPWT) is an adjunct method used in the treatment of diabetic foot ulceration (DFU). Real world data on its effectiveness and safety is scarce. In this prospective observational study, we assessed the short-term efficacy, safety, and long-term outcomes of NPWT in patients with type 2 diabetes (T2DM) and neuropathic, noninfected DFUs.

Methods

Based on wound characteristics, mainly area (>1 vs. ≤1 cm2), 75 patients with DFUs treated in an outpatient clinic were assigned to NPWT (n = 53) or standard therapy (n = 22). Wound area reduction was evaluated after 8 ± 1 days. Long-term outcomes assessed included complete ulceration closure and recurrence rate.

Results

Patients assigned to NPWT were characterized by greater wound area (15.7 vs. 2.9 cm2). Reduction in wound area was found in both the NPWT (−1.1 cm2, −10.2%, p = 0.0001) and comparator group (−0.3 cm2, −18.0%, p = 0.0038). No serious adverse events related to NPWT were noted. Within 1 year, 55.1% (27/49) of DFUs were closed in the NPWT group and 73.7% (14/19) in the comparator group (p = 0.15). In the logistic regression, wound duration and smaller initial area, but not treatment mode, were associated with closure. One-year follow-up after DFU resolution revealed an ~30.0% recurrence rate in both groups (p = 0.88).

Conclusions

NPWT is a safe treatment for neuropathic, nonischemic, and noninfected DFU in patients with T2DM, although this observational study did not prove its effectiveness over standard therapy. Additionally, we report a high rate of both closure and recurrence of ulcers, the latter irrespective of initial ulcer area.



https://ift.tt/2OuhUIY

Paraneoplastic autoimmune multiorgan syndrome (PAMS): Beyond the single phenotype of paraneoplastic pemphigus

Publication date: Available online 11 August 2018

Source: Autoimmunity Reviews

Author(s): Kyle T. Amber, Manuel Valdebran, Sergei A. Grando

Abstract

Paraneoplastic autoimmune multiorgan syndrome (PAMS) is characterized by a heterogenous group of signs and symptoms including severe desquamative stomatitis, a polymorphous cutaneous eruption, humoral immunity against plakin proteins, contribution of cell-mediated autoimmunity and commonly a progressive respiratory failure. Autoantibodies in PAMS target a wide array of antigens including plakins, cadherins, alpha-2-macroglobulin like 1 (A2ML1), BP180, plakophilin-3, and several neuromuscular antigens. Originally described as paraneoplastic pemphigus in 1990 due to some of its clinical and immunologic similarities to classic pemphigus (pemphigus vulgaris and pemphigus foliaceus), PAMS is a multiorganopathy with several distinct features from these classic forms of pemphigus. Epidemiologically, PAMS is associated with underlying neoplasia and has a differing HLA-II allele predisposition compared to classic forms of pemphigus. Clinically, lesion morphology is polymorphous, and lesion distribution fundamentally differs from that seen in classic pemphigus. PAMS has a significantly higher mortality rate and a poorer response to treatments typically effective in pemphigus. Histologically, PAMS is characterized by the presence of interface dermatitis, vacuolar changes, and dyskeratotic keratinocytes which are not seen in classic pemphigus. PAMS demonstrates not only intercellular IgG as seen in classic pemphigus, but the presence of linear basement membrane zone deposition. Antibodies against desmoglein 3 (Dsg3) map to a broader array of epitopes than in pemphigus vulgaris and there is a higher prevalence of complement binding anti-Dsg3 IgG autoantibodies in PAMS. Autoantibodies can in rare cases be absent in the more cell-mediated form of PAMS. Considering these numerable differences, we review the entity of PAMS, and provide similarities and differences to classic forms of pemphigus.



https://ift.tt/2P1JAWP

Recommendations and barriers to vaccination in systemic lupus erythematosus

Publication date: Available online 11 August 2018

Source: Autoimmunity Reviews

Author(s): Megha Garg, Naaima Mufti, Tara Palmore, Sarfaraz Hasni

Abstract

Patients with Systemic Lupus Erythematosus (SLE) pose a unique dilemma pertaining to immunization against common pathogens. SLE patients are usually not immunized with vaccines based on the fear of either precipitating infection in this immunosuppressed patient population (with live vaccines) or aggravating autoimmunity and hence lupus flares (with any vaccines). However, elevated vulnerability to infection makes patients with SLE precisely the population that needs protection from vaccine-preventable diseases. A summary of guidelines from the Centers for Disease Control and Prevention, professional societies, review articles and expert opinions regarding use of individual vaccines applicable to adults with SLE is presented in this review.



https://ift.tt/2KK14nc

Increased risk of thrombosis in antiphospholipid syndrome patients treated with direct oral anticoagulants. Results from an international patient-level data meta-analysis

Publication date: Available online 11 August 2018

Source: Autoimmunity Reviews

Author(s): Virginie DUFROST, Jessie RISSE, Tatiana RESHETNYAK, Maria SATYBALDYEVA, D.U. Yao, Xin-xin YAN, Stella SALTA, Grigorios GEROTZIAFAS, Zhi-Cheng JING, Ismaël ELALAMY, Denis WAHL, Stéphane ZUILY

Abstract

Background: Direct oral anticoagulants (DOACs) are widely used for secondary prevention of venous thromboembolism (VTE) but their clinical efficacy and safety are not established in Antiphospholipid Syndrome (APS) patients. There is only one randomized controlled trial published while others are still ongoing. Many non-randomized studies have been published in this field with conflicting opinions.

Purpose of review: We conducted a systematic review using MEDLINE, EMBASE and Cochrane databases from 2000 until March 2018 regarding APS patients treated with DOACs. We performed a patient-level data meta-analysis to a) estimate the prevalence of recurrent thrombosis in APS patients treated with DOACs in the literature, and b) identify variables associated with recurrent thrombosis.

Results: We identified 47 studies corresponding to 447 APS patients treated with DOACs. Three commercially available DOACs were analyzed: rivaroxaban (n = 290), dabigatran etexilate (n = 144) and apixaban (n = 13). A total of 73 out of 447 patients (16%) experienced a recurrent thrombosis while on DOACs with a mean duration until thrombosis of 12.5 months. Rates of recurrent thromboses were 16.9% and 15% in APS patients receiving either anti-Xa inhibitors or dabigatran respectively. Triple positivity (positivity for all three antiphospholipid antibodies) was associated with a four-fold increased risk of recurrent thrombosis (56% vs 23%; OR = 4.3 [95%CI; 2.3–7.7], p < .0001) as well as a higher number of clinical criteria for APS classification. In patients treated with anti-Xa inhibitors, history of arterial thrombosis was associated with a higher risk of recurrent thrombosis (32% vs 14%; OR = 2.8 [95%CI; 1.4–5.7], p = .006).

In conclusion, DOACs are not effective in all APS patients and should not be used routinely in these patients. Randomized controlled trials assessing clinical efficacy and safety as primary endpoints are underway. In the meantime, a registry of APS patients on DOACs could be proposed to establish in which APS subgroups DOACs would be a safe alternative to warfarin.

Graphical abstract

Unlabelled Image



https://ift.tt/2OU8HL3

Negative-pressure wound therapy for management of chronic neuropathic noninfected diabetic foot ulcerations – short-term efficacy and long-term outcomes

Abstract

Purpose

Negative pressure wound therapy (NPWT) is an adjunct method used in the treatment of diabetic foot ulceration (DFU). Real world data on its effectiveness and safety is scarce. In this prospective observational study, we assessed the short-term efficacy, safety, and long-term outcomes of NPWT in patients with type 2 diabetes (T2DM) and neuropathic, noninfected DFUs.

Methods

Based on wound characteristics, mainly area (>1 vs. ≤1 cm2), 75 patients with DFUs treated in an outpatient clinic were assigned to NPWT (n = 53) or standard therapy (n = 22). Wound area reduction was evaluated after 8 ± 1 days. Long-term outcomes assessed included complete ulceration closure and recurrence rate.

Results

Patients assigned to NPWT were characterized by greater wound area (15.7 vs. 2.9 cm2). Reduction in wound area was found in both the NPWT (−1.1 cm2, −10.2%, p = 0.0001) and comparator group (−0.3 cm2, −18.0%, p = 0.0038). No serious adverse events related to NPWT were noted. Within 1 year, 55.1% (27/49) of DFUs were closed in the NPWT group and 73.7% (14/19) in the comparator group (p = 0.15). In the logistic regression, wound duration and smaller initial area, but not treatment mode, were associated with closure. One-year follow-up after DFU resolution revealed an ~30.0% recurrence rate in both groups (p = 0.88).

Conclusions

NPWT is a safe treatment for neuropathic, nonischemic, and noninfected DFU in patients with T2DM, although this observational study did not prove its effectiveness over standard therapy. Additionally, we report a high rate of both closure and recurrence of ulcers, the latter irrespective of initial ulcer area.



https://ift.tt/2OuhUIY

Scholar : Autophagy, Volume 14, Issue 7, 2018 is now available online on Taylor & Francis Online

Taylor & Francis Online - The new journals and reference work platform for Taylor & Francis
The online platform for Taylor & Francis Online content

Autophagy, Volume 14, Issue 7, 2018 is now available online on Taylor & Francis Online.



This new issue contains the following articles:

Editor's Corner

CCPG1 is a noncanonical autophagy cargo receptor essential for reticulophagy and pancreatic ER proteostasis
Vikramjit Lahiri & Daniel J. Klionsky
Pages: 1107-1109 | DOI: 10.1080/15548627.2018.1467199


Review

Mechanisms and context underlying the role of autophagy in cancer metastasis
Christopher M. Dower, Carson A. Wills, Steven M. Frisch & Hong-Gang Wang
Pages: 1110-1128 | DOI: 10.1080/15548627.2018.1450020


Research Paper–Basic Science

Cholesterol impairs autophagy-mediated clearance of amyloid beta while promoting its secretion | Open Access
Elisabet Barbero-Camps, Vicente Roca-Agujetas, Isabel Bartolessis, Cristina de Dios, Jose C. Fernández-Checa, Montserrat Marí, Albert Morales, Tobias Hartmann & Anna Colell
Pages: 1129-1154 | DOI: 10.1080/15548627.2018.1438807


Autophagic Punctum

An atypical BAR domain protein in autophagy
Hana Popelka, Daniel J. Klionsky & Michael J. Ragusa
Pages: 1155-1156 | DOI: 10.1080/15548627.2018.1445915


Defective autophagy degradation and abnormal tight junction-associated signaling drive epithelial dysfunction in cystinosis
Alessandro Luciani, Beatrice Paola Festa, Zhiyong Chen & Olivier Devuyst
Pages: 1157-1159 | DOI: 10.1080/15548627.2018.1446625


A ubiquitin-dependent mitophagy complex maintains mitochondrial function and insulin secretion in beta cells
Gemma Pearson & Scott A. Soleimanpour
Pages: 1160-1161 | DOI: 10.1080/15548627.2018.1446627


Aspirin—another caloric-restriction mimetic
Federico Pietrocola, Francesca Castoldi, Maria Chiara Maiuri & Guido Kroemer
Pages: 1162-1163 | DOI: 10.1080/15548627.2018.1454810


Research Paper - Basic Science

Novel insight into circular RNA HECTD1 in astrocyte activation via autophagy by targeting MIR142-TIPARP: implications for cerebral ischemic stroke
Bing Han, Yuan Zhang, Yanhong Zhang, Ying Bai, Xufeng Chen, Rongrong Huang, Fangfang Wu, Shuo Leng, Jie Chao, John H. Zhang, Gang Hu & Honghong Yao
Pages: 1164-1184 | DOI: 10.1080/15548627.2018.1458173


Silica nanoparticles induce autophagosome accumulation via activation of the EIF2AK3 and ATF6 UPR pathways in hepatocytes
Ji Wang, Yang Li, Junchao Duan, Man Yang, Yang Yu, Lin Feng, Xiaozhe Yang, Xianqing Zhou, Zhendong Zhao & Zhiwei Sun
Pages: 1185-1200 | DOI: 10.1080/15548627.2018.1458174


Poliovirus induces autophagic signaling independent of the ULK1 complex
Angel Corona Velazquez, Abigail K. Corona, Kathryn A. Klein & William T. Jackson
Pages: 1201-1213 | DOI: 10.1080/15548627.2018.1458805


Improved efficacy of mitochondrial disrupting agents upon inhibition of autophagy in a mouse model of BRCA1-deficient breast cancer
Syn Kok Yeo, Ritama Paul, Michael Haas, Chenran Wang & Jun-Lin Guan
Pages: 1214-1225 | DOI: 10.1080/15548627.2018.1460010


Inhibiting autophagy reduces retinal degeneration caused by protein misfolding
Jingyu Yao, Yaoyan Qiu, Eric Frontera, Lin Jia, Naheed W. Khan, Daniel J. Klionsky, Thomas A. Ferguson, Debra A. Thompson & David N. Zacks
Pages: 1226-1238 | DOI: 10.1080/15548627.2018.1463121


ROS is the major player in regulating altered autophagy and lifespan in sin-3 mutants of C. elegans
Meenakshi Sharma, Renu Pandey & Daman Saluja
Pages: 1239-1255 | DOI: 10.1080/15548627.2018.1474312


Toolbox

A novel Atg5-shRNA mouse model enables temporal control of Autophagy in vivo | Open Access
Liam D. Cassidy, Andrew RJ. Young, Pedro A. Pérez-Mancera, Birgit Nimmervoll, Adil Jaulim, Hung-Chang Chen, Dominick J. O. McIntyre, Rebecca Brais, Thomas Ricketts, Simon Pacey, Maike De La Roche, Richard J. Gilbertson, David C. Rubinsztein & Masashi Narita
Pages: 1256-1266 | DOI: 10.1080/15548627.2018.1458172


Commentary

CMA restricted to mammals and birds: myth or reality?
Laury Lescat, Amaury Herpin, Brigitte Mourot, Vincent Véron, Yann Guiguen, Julien Bobe & Iban Seiliez
Pages: 1267-1270 | DOI: 10.1080/15548627.2018.1460021


Autophagic Punctum

Cdk5-mediated Acn/Acinus phosphorylation regulates basal autophagy independently of metabolic stress
Nilay Nandi & Helmut Krämer
Pages: 1271-1272 | DOI: 10.1080/15548627.2018.1441472


Targeting autophagy for therapy of hyperammonemia
Leandro R. Soria & Nicola Brunetti-Pierri
Pages: 1273-1275 | DOI: 10.1080/15548627.2018.1444312


Age-associated and tissue-specific decline in autophagic activity in the nematode C. elegans
Jessica T. Chang & Malene Hansen
Pages: 1276-1277 | DOI: 10.1080/15548627.2018.1445914


Commentary

Metformin reduces TRIB3 expression and restores autophagy flux: an alternative antitumor action
Ke Li, Ting-ting Zhang, Fang Hua & Zhuo-wei Hu
Pages: 1278-1279 | DOI: 10.1080/15548627.2018.1460022


Phasing out the bad—How SQSTM1/p62 sequesters ubiquitinated proteins for degradation by autophagy | Open Access
Gabriele Zaffagnini, Adriana Savova, Alberto Danieli, Julia Romanov, Shirley Tremel, Michael Ebner, Thomas Peterbauer, Martin Sztacho, Riccardo Trapannone, Abul K. Tarafder, Carsten Sachse & Sascha Martens
Pages: 1280-1282 | DOI: 10.1080/15548627.2018.1462079


The anti-apoptotic ubiquitin conjugating enzyme BIRC6/BRUCE regulates autophagosome-lysosome fusion | Open Access
Fumiyo Ikeda
Pages: 1283-1284 | DOI: 10.1080/15548627.2018.1471311


Denitrosylate and live longer: how ADH5/GSNOR links mitophagy to aging
Salvatore Rizza & Giuseppe Filomeni
Pages: 1285-1287 | DOI: 10.1080/15548627.2018.1475818


EIF5A mediates autophagy via translation of ATG3
Lisa B. Frankel
Pages: 1288-1289 | DOI: 10.1080/15548627.2018.1491213


Corrigendum

Corrigendum
Pages: 1290-1290 | DOI: 10.1080/15548627.2018.1467195


To update which email alerts you receive, manage your alerts within the My Account area.

Unsubscribe from new content alerts for this journal (both new issue and latest article notifications) with one click.

If you need any further help, please contact us at support@tandfonline.com

Please do not reply to this email. To ensure that you receive your alerts and information from Taylor & Francis Online, please add "alerts@tandfonline.com" and "info@tandfonline.com" to your safe senders list.

Taylor & Francis, an Informa business.
Taylor & Francis is a trading name of Informa UK Limited, registered in England under no. 1072954. Registered office: 5 Howick Place, London, SW1P 1WG.



Scholar : ΓΛΩΣΣΙΤΙΣ - νέα αποτελέσματα

[HTML] Significantly higher frequencies of anemia, hematinic deficiencies, hyperhomocysteinemia, and serum gastric parietal cell antibody positivity in atrophic glossitis …

CP Chiang, JYF Chang, YP Wang, YC Wu, YH Wu… - Journal of the Formosan …, 2018
Background/Purpose Atrophic glossitis (AG) patients are prone to have anemia,
hematinic deficiencies, hyperhomocysteinemia, and serum gastric parietal cell
antibody (GPCA) positivity. This study evaluated whether 1064 AG patients had …
Google+ Facebook Twitter

[PDF] PREVALENCE OF ORAL MUCOSAL LESIONS IN NONORAL HABIT DIABETIC PATIENTS AND NORMAL SUBJECTS

ZA Bhat, AH Chalkoo, R Hamid, S Tariq, DP Sharma - PARIPEX-INDIAN JOURNAL …, 2018
… Inflammatory such as gingivitis, periodontitis, candidiasis, stomatitis, benign
migratory glossitis or geographic tongue, median rhomboid glossitis and
angular cheilitis [5 9]. bacterial and fungal infections are more in diabetic …
Google+ Facebook Twitter

[HTML] Oral lesions secondary to visceral leishmaniasis in a dog with endogenous hyperadrenocorticism: case report

MS Bochnakian, JAB Bezerra, K Fernandes, VR Barros… - Arquivo Brasileiro de …, 2018
… [ Links ]. FOGLIA MANZILLO, V.; PAGANO, A.; PACIELLO, O. et al.
Papular-like glossitis in a dog with leishmaniosis. Vet. Rec., v.156,
p.213-215, 2005. [ Links ]. LAMOTHE, J.; POUJADE, A. Ulcerative glossitis …
Google+ Facebook Twitter

Review of Liver Disease and Perioperative Management in Dentistry

H Ephros, IL Garibyan - Hemostasis in Dentistry, 2018
… Also, glossitis may be seen in patients with alcoholic hepatitis [8] and alcohol-related
nutritional deficiencies (see Figs. 6.1 and 6.2) … 6.1. Fig. 6.1 Tongue of chronic alcoholic.
Open image in new window Fig. 6.2. Fig. 6.2 Glossitis from nutritional deficiencies …
Google+ Facebook Twitter

[PDF] Anemia and associated factors in women at reproductive age in a Brazilian Northeastern municipality

AGN BezerraI, VS LealII, PIC de LiraIII, JS OliveiraII… - Rev BRas epidemiol, 2018
… Due to the reduced concentration of blood hemoglobin, the transport of
oxygen to the body tissues is compromised, causing changes in the aspect
of the skin and mucosa, with consequent paleness, glossitis, fatigue …
Google+ Facebook Twitter

The vitamin epidemic: what is the evidence for harm or value?

M Kennedy - Internal Medicine Journal, 2018
… Riboflavin (vitamin B 2 ). Riboflavin exists in two active forms: flavin mononucleotide and
flavin adenine dinucleotide, and is a requirement for carbohydrate and lipid metabolism.
Dietary deficiency causes angular stomatitis, glossitis and dermatitis …
Google+ Facebook Twitter

[PDF] Sextuple tumors in head and neck area: evidence of field cancerization Running Title: Field cancerization and sextuple tumors

CB Nelem-Colturato, PM Cury, TM Pereira, IS Cosso…
… in right tonsillar pillar, diagnosed as SCC, which is the fifth malignant tumor. Forty-six
months after the diagnostic the first malignancy, patient developed symptomatic lesions
in base of tongue diagnosed as nonspecific chronic glossitis. The tissue Page 4. 4 …
Google+ Facebook Twitter

[HTML] Featured Case: UR3 on UR2

DB Giddon
Close. Login. Create New Account. message boards. today's active topics today's
active cases browse categories my recent activity my messages my private groups
my marked threads. today's active images today's active polls …
Google+ Facebook Twitter

 

Αυτή η ειδοποίηση αποστέλλεται από τον Μελετητή Google. Ο Μελετητής Google είναι μια υπηρεσία που παρέχεται από την Google.



Scholar : CPAP - νέα αποτελέσματα

Oxyhemoglobin Resaturation following Obstructive Breathing Events Mitigates Sleep Apnea-Induced Glucose Elevations

LV Pham, AR Schwartz, JC Jun - Frontiers in Endocrinology, 2018
… in glucose regulation and diabetes. We recently showed that CPAP withdrawal in
patients with moderate-severe OSA leads to dynamic within-night glucose elevations
in proportion to the severity of IH. In the present study, we …
Google+ Facebook Twitter

Investigating the structure and function of HSV-1 tegument proteins: UL7 and UL51

D Owen - 2018
… An interaction between UL51 and the G-Box domain of the centriole protein CPAP was
identified by Y2H screen, and validated by immunoprecipitation from transfected cells
and in pull-down experiments using recombinant proteins purified from E. coli …
Google+ Facebook Twitter

[HTML] Recent advances in anesthesia of the obese patient

JB Brodsky - F1000Research, 2018
… insufflation ventilatory exchange" (THRIVE). THRIVE combines the benefits of apneic
oxygenation with continuous positive airway pressure (CPAP) and gas exchange
through flow-dependent dead-space flushing. THRIVE using 70 …
Google+ Facebook Twitter

Upper Airway Stimulation in Patients Who Have Undergone Unsuccessful Prior Palate Surgery: An Initial Evaluation

C Huntley, A Vasconcellos, K Doghramji, B Hofauer… - Otolaryngology–Head and …, 2018
Upper airway stimulation therapy (UAS) is a new option for treatment of obstructive sleep
apnea (OSA) in patients unable to tolerate continuous positive airway ...
Google+ Facebook Twitter

[PDF] Low-cost adjustable mandibular advancement device for obstructive sleep apnea

S Upadhyay, SV Singh, D Arya, P Chand, RD Singh - J Dent Sleep Med, 2018
… MADs dilate or open the airway by anterior positioning of the mandible
during sleep to relieve snoring and OSA.6 They are especially helpful to
patients intolerant to CPAP because of nasal stuffiness, dryness, and …
Google+ Facebook Twitter

Comparison of Patient-and Parent-Reported Quality of Life for Patients Treated for Persistent Obstructive Sleep Apnea

M Bergeron, AL Duggins, AP Cohen, SL Ishman - Otolaryngology–Head and Neck …, 2018
Objectives To evaluate the impact of the treatment of persistent pediatric obstructive sleep
apnea (OSA) on quality of life (QOL) with patient-reported outcomes...
Google+ Facebook Twitter

[PDF] Parameter identifiability of a respiratory mechanics model in an idealized preterm infant

LE Fix - arXiv preprint arXiv:1808.00998, 2018
… Our model is the first known attempt to represent these dynamics that account
for the physiol- ogy particular to premature infants, and depict the mitigating
effects of expiratory laryngeal braking (grunting) and continuous positive …
Google+ Facebook Twitter

Beyond Resistant Hypertension: Relationship Between Refractory Hypertension and Obstructive Sleep Apnea

MA Martínez-García, C Navarro-Soriano, G Torres… - Hypertension, 2018
… when associated with RH, in which case the prevalence of OSA reaches
levels of 71% to 90%.11–14 The main pathophysi- ological pathway by which
OSA triggers an increase in BP is the sympathetic system activation.15–17 …
Google+ Facebook Twitter

Prediction of ROP Treatment and Evaluation of Screening Criteria in VLBW Infants–a Population Based Analysis

R Gerull, V Brauer, D Bassler, B Laubscher, RE Pfister… - Pediatric Research, 2018
… The final model contained the following 5 risk factors: GA, birth weight z-score, CPAP >
3 days, multiple birth and surfactant … All rights reserved. Page 7. supplemental oxygen,
CPAP and mechanical ventilation was measured as number of days …
Google+ Facebook Twitter

Clinicopathological case: progressive somnolence and dementia in an accountant: when the shine rubs off the gold standard

T Soane, JM Schott, J Stone, C Smith, RJ Davenport - 2018
… He was diagnosed with sleep apnoea, and initially responded well to continuous positive
airway pressure (CPAP), but by mid-2015 was sleeping up to 20 hours/day … He was
diagnosed with obstructive sleep apnoea and initially responded well to CPAP …
Google+ Facebook Twitter

 

Αυτή η ειδοποίηση αποστέλλεται από τον Μελετητή Google. Ο Μελετητής Google είναι μια υπηρεσία που παρέχεται από την Google.



Αναζήτηση αυτού του ιστολογίου